G Cruciani

Progress in predicting human ADME parameters in silico.

S. Ekins, P. Swaan, J. Wikel, 2000, Journal of pharmacological and toxicological methods.

VolSurf: a new tool for the pharmacokinetic optimization of lead compounds.

M Pastor, W Guba, W. Guba, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype.

M Pastor, A. Smilde, H. Wikström, 1997, Journal of medicinal chemistry.

Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.

G. Cruciani, K. Watson, G Cruciani, 1994, Journal of medicinal chemistry.

A search for specificity in DNA-drug interactions.

P J Goodford, P. Goodford, G. Cruciani, 1994, Journal of Molecular Graphics.

Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors.

M Pastor, R C Wade, R. Wade, 1997, Journal of medicinal chemistry.

Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships.

M Pastor, M. Pastor, G. Cruciani, 1997, Journal of medicinal chemistry.

A novel strategy for improving ligand selectivity in receptor-based drug design.

M Pastor, M. Pastor, G. Cruciani, 1995, Journal of medicinal chemistry.